Your Article Summary
See Latest ArticlesImmune-based therapy for chronic hepatitis C
Journal of Leukocyte Biology, 07/02/09
Chang DY et al. - These immune-based therapies for chronic HCV infection include therapeutic vaccines, antagonists of T cell inhibitory factors, anti-HCV neutralizing antibodies, cytokines, and agonists for TLRs. Currently, various types of immune-based therapies are under development that might be used as a monotherapy or in combination with other antiviral drugs for the treatment of chronic HCV infection.
Related Articles
Sporadic cases of acute autochthonous hepatitis E virus infection in Southwest Germany
Journal of Clinical Virology, 11/16/09
Relevance Score: 91%
Liver enzyme abnormalities in systemic lupus erythematosus: A focus on toxic hepatitis
Rheumatology International, 11/13/09
Relevance Score: 91%
De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation
Liver Transplantation, 10/30/09
Relevance Score: 91%
Reactivation of Hepatitis B With Reappearance of Hepatitis B Surface Antigen After Chemotherapy and Immunosuppression
Clinical Gastroenterology and Hepatology, 10/09/09
Relevance Score: 91%
FOXP3 Expression in Hepatitis C Virus-Specific CD4+ T Cells During Acute Hepatitis C
Gastroenterology, 10/06/09
Relevance Score: 91%
Today in Hepatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) – lack of interference by iron deposition
British Journal of Haematology, 11/30/09
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial
The Lancet Oncology - Online First, 11/30/09
Optimizing the treatment of chronic viral hepatitis C
Expert Review of Gastroenterology & Hepatology, 11/30/09